Losses
-€13,185 in two years
The 2012 and 2013 financial years closed with a loss. 2012 was the heaviest.
BIOLIGN
Overview
Lifetime
2 annual accounts with figures on one time axis, 5 filings since 2009peak -€4,376 (2013)
-€4,376▲ €4,123
lowest -€8,655 (2012)
-€4,530▲ €4,125
peak €9,016 (2012)
€4,486▼ 50.2%
-not published
Owners2 names in the annual accounts
16.73%CRESCENDO
Documentsfilings and deeds
16-05-2014filed
2013abbreviated format
Gross margin from -€8,499 to -€4,376Loss of €4,530Equity from €9,016 to €4,486
Key points
from the 2013 annual accounts, the last ones filedFilings
5 annual accounts since 2009
The last five annual accounts were filed 64 to 76 days before the end of the period.
No scoreTurnover not published (abbreviated format)
Recent changes
Deed on the end
Gazette deed
Incorporation
4 publications in the Belgian Official Gazette, the last on 27-06-2014 · Gazette deed
Official details
Source: KBO- Status
- Inactivedeed of incorporation of 16-07-2008 · last publication under the heading End on 27-06-2014
- Activity
- No activity registered in the KBO
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Annual accounts 2013
- -€4,376▲ 48.5%
- €4,530▼ 47.7%
- €4,486▼ 50.2%
- €7,990▼ 18.4%
- Filing
- Filed on 16-05-2014
Insights on BIOLIGN
Inactive. The last annual accounts are for financial year 2013.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2013
abbreviated format, filed on 16-05-2014, 76 days before the deadline-€4,376
▲ €4,123
-€4,499
▲ €4,121
-€4,530
▲ €4,125
-
56.1%
▼ 35.9 percentage points
-
Turnover and EBIT margin are not published. The abbreviated format does not require them.
Balance sheet
balance sheet total €7,990 on 31-12-2013What the company ownsHow it is paid for
in euro
in euro
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2013 | 2012 |
|---|---|---|---|
| Balance sheet: assets | |||
20/58 |
7,990 | 9,792 | |
29/58 |
7,990 | 9,792 | |
40/41 |
267 | 175 | |
41 |
267 | 175 | |
54/58 |
7,723 | 9,617 | |
| Balance sheet: equity and liabilities | |||
10/49 |
7,990 | 9,792 | |
10/15 |
4,486 | 9,016 | |
10/11 |
106,400 | 106,400 | |
100 |
106,400 | 106,400 | |
14 |
-101,914 | -97,384 | |
16 |
3,504 | - | |
160/5 |
3,504 | - | |
17/49 |
- | 776 | |
42/48 |
- | 776 | |
44 |
- | 776 | |
440/4 |
- | 776 | |
| Income statement | |||
9900 |
-4,376 | -8,499 | |
640/8 |
123 | 121 | |
9901 |
-4,499 | -8,620 | |
75/76B |
4 | 12 | |
75 |
4 | 12 | |
65/66B |
35 | 47 | |
65 |
35 | 47 | |
9903 |
-4,530 | -8,655 | |
9904 |
-4,530 | -8,655 | |
9905 |
-4,530 | -8,655 | |
| Appropriation of the result | |||
9906 |
-101,914 | -97,384 | |
| Document | |||
The accounts for 3 older financial years (2009-2011) were filed as documents without figures as data, scans for example.
Source: Annual accounts 2013 (PDF), filed on 16-05-2014.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2013 | abbreviated format | 16-05-2014 | 2014-12700050 | |
| 31-12-2012 | abbreviated format | 24-05-2013 | 2013-13100183 | |
| 31-12-2011 | abbreviated format | 24-05-2012 | 2012-13100198 | |
| 31-12-2010 | abbreviated format | 26-05-2011 | 2011-12900286 | |
| 31-12-2009 | abbreviated format | 28-05-2010 | 2010-13800293 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2013 | 2012 |
|---|---|---|---|
| -1,894 | - | ||
| - | 9,016 | ||
| 56.1% | 92.1% | ||
| - | 12.62 | ||
| - | 0.09 | ||
| -101.0% | -96.0% | ||
| -56.7% | -88.4% |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on BIOLIGN
The operating result for 2013 is a loss of €4,499, smaller than the loss of €8,620 in 2012.
Board & ownership
Control
Capital
- Capital
- €106,400
- Source
- 2013 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
- CRESCENDO
- VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE - FLANDERS INSTITUTE FOR BIOTECHNOLOGY
Source: lists of holdings in the owners' accounts
Timeline
Timeline
7 events since 2008Filings
End
2008201020122014201620182020202220242026
2014
Deed on the end PDF
Annual accounts 2013 filed PDFabbreviated format · 76 days before the deadline
2013
Annual accounts 2012 filed PDFabbreviated format · 68 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 68 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 66 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 64 days before the deadline
2008
Incorporation PDF4 publications in the Belgian Official Gazette, the last on 27-06-2014
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
Company details
Inactive
BIOLIGN is no longer in the KBO register.
- Last annual accounts
- financial year to 31 December 2013
- Last registered office
- Rijvisschestraat 120, 9052 Zwijnaardeas published on 27 June 2014
- Legal form
- Public limited company
- First annual accounts
- financial year 2009